LGVN Longeveron Inc.: Company Short-Term Debts

Public company logo of Longeveron Corporation (LGVN)

Longeveron Inc. (LGVN) is a regenerative medicine innovator developing cellular methods to combat aging. The short-term debt profile illustrates the dynamics of one-year obligations, where the current parameter equals 0.00. Transparent R&D expenditure control by management and high authority within medical circles sustain investor interest as the market awaits clinical trial results.

LGVN (Longeveron) Short-Term Debt history from 07/04/2022 to 10/31/2026

Longeveron Corporation - analytical breakdowns and key metrics (LGVN)

- current quotes and average value forecast:
Price Chart Longeveron|LGVN - Consensus Target
- company stock capitalization data:
Market Capitalization Longeveron Inc.|LGVN - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share Longeveron|LGVN - Total Stockholders' Equity|Market Value to Book Value Ratio longeveron.com|LGVN - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Longeveron Inc.|LGVN - Long-Term Debt to Equity|Short-Term Debt to Equity Longeveron Inc.|LGVN - Company Total Debt Obligations|Debt to Book Capitalization Ratio Longeveron Inc.|LGVN - Company Long-Term Debt|Company Short-Term Debt Longeveron|Quick Liquidity longeveron.com
- net income and valuation multiples indicators:
LGVN - Company Profit
Fundamental company analysis:LGVN - Longeveron
Mass-produced product of Longeveron Inc.

To assess the long-term sustainability of Longeveron Inc. (LGVN), it is critical to monitor the total volume of liabilities maturing within one year, which allows for the rapid diagnosis of cash gap risks through short-term creditor burdens. This metric, calculated on a daily basis, determines the company's liquidity required to fund bioreactor automation and scale the production of cell therapies without compromising operational activities.

Competitor analysis for Longeveron Inc.

MESO - Company Short-Term Debt|Lineage Cell Therapeutics Inc (LCTX) - Company Current Liabilities|SRZN: Company Short-Term Debts|Company Current Liabilities Cryo-Cell International, Inc.|FBLG (FibroBiologics Inc.) - Company Short-Term Debts|Short-Term Debt BioRestorative BRTX|Company Short-Term Debt Creative Medical Technology (CELZ)